Another study showed that allogeneic and syngeneic clonal BMSCs exhibited therapeutic effects on AD, possibly by suppressing T cell and B cell functions, decreasing the serum IgE level, and inhibiting cell infiltration in skin lesions and the expression of IL-4 in the lymph node and skin [135]. The gene discussed is IGHE; the disease is Alzheimer disease.